Kushal Umeshbhai Agrawal
Research Subjects
Kushal Umeshbhai Agrawal has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Chetna Bakshi
Ocular Oncology Department, Jupiter Hospital, Thane, Maharashtra, India
1 shared publicationKashmira Limaye Joshi
Microbiology, Jupiter Hospital, Thane, India
1 shared publicationMaikel Gad
Biochemistry, Middle Tennessee State University, Murfreesboro, Tennessee, USA
1 shared publicationParag K. Shah
Department of Ocular Oncology and Paediatric Retina, Aravind Eye Hospital, Coimbatore, India
1 shared publicationSupriya Dutta
Ocular Oncology Department, Jupiter Hospital, Thane, Maharashtra, India
1 shared publication
Latest Publications
- Open Access
- 1 July 2023
- Published by Medknow in Indian Journal of Ophthalmology - Case Reports
- Vol. 3 (3) , 781-783
Acute myeloid leukemia relapsing in the vitreous
A 47-year-old female was a known case of acute myeloid leukemia (AML-M5) and presented with a diminution of vision in the right eye (OD) for two weeks. Examination revealed pigmented cells in the anterior vitreous of both eyes with vitritis OD. She was further treated with vitreous biopsy and diagnostic vitrectomy under air OD. The cytology examination of the vitreous biopsy revealed infiltration with myeloblasts confirming the diagnosis of extramedullary relapse of AML inside the vitreous. She was further treated with intrathecal chemotherapy. She did not have any further relapse till two years after her last follow-up. This case highlights a rare location of extramedullary relapse of AML inside the vitreous which has not been reported as per the literature search. Moreover, diagnostic vitrectomy under air helped in getting more undiluted vitreous fluid, which also helped in confirming the relapse with cytology examination.
- 1 July 2023
- Published by Medknow in Indian Journal of Ophthalmology - Case Reports
- Vol. 3 (3) , 781-783
Open AccessAcute myeloid leukemia relapsing in the vitreous
A 47-year-old female was a known case of acute myeloid leukemia (AML-M5) and presented with a diminution of vision in the right eye (OD) for two weeks. Examination revealed pigmented cells in the anterior vitreous of both eyes with vitritis OD. She was further treated with vitreous biopsy and diagnostic vitrectomy under air OD. The cytology examination of the vitreous biopsy revealed infiltration with myeloblasts confirming the diagnosis of extramedullary relapse of AML inside the vitreous. She was further treated with intrathecal chemotherapy. She did not have any further relapse till two years after her last follow-up. This case highlights a rare location of extramedullary relapse of AML inside the vitreous which has not been reported as per the literature search. Moreover, diagnostic vitrectomy under air helped in getting more undiluted vitreous fluid, which also helped in confirming the relapse with cytology examination.
- 13 April 2023
- Published by Elsevier in Ophthalmology Retina
- Vol. 7 (6) , e7-E7
Re: Verma et al.: Salvage intra-arterial chemotherapy for recurrent or persistent intraocular retinoblastoma: a study of 24 eyes (Ophthalmol Retina. 2022;7:275-281)
- 13 April 2023
- Published by Elsevier in Ophthalmology Retina
- Vol. 7 (6) , e7-E7
Re: Verma et al.: Salvage intra-arterial chemotherapy for recurrent or persistent intraocular retinoblastoma: a study of 24 eyes (Ophthalmol Retina. 2022;7:275-281)
- 22 November 2021
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 31 (1) , 123-126
A Rare Case of Fulminant Acute Postoperative Morganella morganii Endophthalmitis
Purpose: The authors present a case of a 60-year-old Indian female presented with sudden loss of vision in the right eye three days after an uneventful cataract surgery which revealed a rare organism and which was treated successfully. Methods: She was diagnosed with acute postoperative endophthalmitis with fulminant disease and on further work up, culture showed Morganella morganii (gram negative bacilli). Results: She was successfully treated with intravitreal imipenem, dexamethasone and vitrectomy. A review of literature was conducted to identify and discuss additional reports on similar cases. As per PubMed search with keywords “Morganella morganii endophthalmitis” this is the best achieved visual outcome to date in a case of acute post-operative Morganella morganii endophthalmitis. Conclusion: Intravitreal imipenem can be considered to treat Morganella morganii endophthalmitis. Aggressive treatment in these patients can help in improving visual outcome.
- 22 November 2021
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 31 (1) , 123-126
A Rare Case of Fulminant Acute Postoperative Morganella morganii Endophthalmitis
Purpose: The authors present a case of a 60-year-old Indian female presented with sudden loss of vision in the right eye three days after an uneventful cataract surgery which revealed a rare organism and which was treated successfully. Methods: She was diagnosed with acute postoperative endophthalmitis with fulminant disease and on further work up, culture showed Morganella morganii (gram negative bacilli). Results: She was successfully treated with intravitreal imipenem, dexamethasone and vitrectomy. A review of literature was conducted to identify and discuss additional reports on similar cases. As per PubMed search with keywords “Morganella morganii endophthalmitis” this is the best achieved visual outcome to date in a case of acute post-operative Morganella morganii endophthalmitis. Conclusion: Intravitreal imipenem can be considered to treat Morganella morganii endophthalmitis. Aggressive treatment in these patients can help in improving visual outcome.